Recursion's AI-designed cancer drugs REC-3565 and REC-617 show early clinical promise, with one patient responding ...

Regions Financial shows improving fundamentals, strong Q2 results, and solid credit quality, but trades near fair value. Find ...

CWM LLC has more than doubled its stake in Regeneron Pharmaceuticals, snapping up an additional 2,007 shares to now hold a ...